An Update in Osteoporosis – What is New in 2020
Aliya Khan, MD, FRCPC, FACP, FACE
Topics: Osteoporosis
Details
Objectives
- To review the indication for starting and stopping treatment.
- To appreciate the efficacy and limitations of current treatments.
- To review new treatment options and possibilities based on advances in bone biology
- To understand what may/will new treatments provide
Faculty
Aliya Khan MD, FRCPC, FACP, FACE
Clinical Professor of Medicine,
Endocrinology and Geriatrics at McMaster University,
Director of the Calcium Disorders Clinic and Director of the Fellowship program in Metabolic Bone Disease at McMaster University
She graduated with honours from the University of Ottawa Medical School and trained in Internal Medicine, Geriatrics and Endocrinology at the University of Toronto.
She completed a fellowship in Metabolic Bone Disease at the University of Toronto. She has over 150 scientific publications and book chapters on metabolic bone disease as well as parathyroid disease. She has been recognized by numerous national and international awards including the Queen's Diamond Jubilee Medal for 2012 for excellence in clinical care, research and teaching. She has also received the International Hypoparathyroidism Award for 2014 and the International Osteoporosis Foundation award for publishing excellence in 2017.
In 2019 she was recognized as being in the top 0.1% of the world experts in hyperparathyroidism by Expertscape.